Cross-sectional and longitudinal study of age-related phalangeal bone loss in adult females
Authors:
- 1 June 1993
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 8 (6) , 685-691
Abstract
To establish a comprehensive model for peripheral phalangeal bone loss, bone mass was studied in 1984 and 1989 using quantitative microdensitometry (QMD) in a total of 330 healthy women (age range 43–78.7 years). Bone mass and changes in bone mass were analyzed in relation to age and menopausal status. Ideal and nonideal populations were distinguished to assess the effect of diseases and medication. Both groups showed a decrease in bone mass, which proved to be more dependent on menopausal status than on age. A substantial loss started in the ideal group in the early postmenopausal period and in the nonideal group in the premenopausal period. Because the nonideal group started to lose bone at an earlier stage, the lifetime risk for osteoporosis is higher than in the ideal group.Keywords
Funding Information
- Praeventiefonds (002817900)
This publication has 27 references indexed in Scilit:
- Improved vertebral fracture threshold in postmenopausal osteoporosis by radiogrametric measurements: Its usefulness in selection for preventive therapyJournal of Bone and Mineral Research, 1991
- Estrogens, bone loss and preservationOsteoporosis International, 1990
- Which bone to measureOsteoporosis International, 1990
- Bone densitometry of the appendicular and axial skeletonTopics in Geriatric Rehabilitation, 1989
- Measurement of spinal or peripheral bone mass to estimate early postmenopausal bone loss?The American Journal of Medicine, 1988
- The dom project for the early detection of breast cancer, Utrecht, The NetherlandsJournal of Chronic Diseases, 1984
- On Aging Bone LossClinical Orthopaedics and Related Research, 1982
- BONE MASS IN POSTMENOPAUSAL WOMEN AFTER WITHDRAWAL OF OESTROGEN/GESTAGEN REPLACEMENT THERAPYThe Lancet, 1981
- BONE RESPONSE TO TERMINATION OF ŒSTROGEN TREATMENTThe Lancet, 1978
- Age and activity effects on rate of bone mineral loss.Journal of Clinical Investigation, 1976